---
title: "Yunnan Baiyao: Xiangsha Pingwei Granules have obtained the drug supplementary application approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259959043.md"
description: "According to Yunnan Baiyao, recently, the sugar-free research project of the Xiangsha Pingwei granules, jointly undertaken by the Central Research Institute of Yunnan Baiyao Group and the Pharmaceutical Business Group, has received the supplementary application approval from the National Medical Products Administration"
datetime: "2025-10-04T13:15:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259959043.md)
  - [en](https://longbridge.com/en/news/259959043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259959043.md)
generator: "portal-rs"
---

# Yunnan Baiyao: Xiangsha Pingwei Granules have obtained the drug supplementary application approval

According to Yunnan Baiyao, the sugar-free research project for the Xiangsha Pingwei Granules, jointly undertaken by the Central Research Institute of Yunnan Baiyao Group and the Pharmaceutical Business Group, has received the supplementary application approval from the National Medical Products Administration

### Related Stocks

- [000538.CN](https://longbridge.com/en/quote/000538.CN.md)

## Related News & Research

- [Baidu: AI Cloud Infra and GPU cloud drove growth and margin gains despite overall revenue decline](https://longbridge.com/en/news/296242242.md)
- [Baidu: AI-powered business growth offset revenue decline, with strong cash flow and global expansion](https://longbridge.com/en/news/296208127.md)
- [Hong Kong Cyclothon returns with new extended ‘five tunnels, three bridges’ route](https://longbridge.com/en/news/296340932.md)
- [EXPLAINER-Why a super El Niño leaves tropical commodities acutely exposed](https://longbridge.com/en/news/296197492.md)
- [Icelandic Salmon to present Q2 2026 results via Teams webinar](https://longbridge.com/en/news/296591911.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**